F. L. van de Veerdonk

Immunology · 2011–2021

A researcher in the Science corpus: 15 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Immunology — 99 citations into it

Whom F. L. van de Veerdonk trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Gordon D. Brown
2. Benjamin N. Gantner
3. O. Gross

Papers from F. L. van de Veerdonk's perspective

Ordered by how strongly the researchers F. L. van de Veerdonk trusts endorse each paper. Same corpus, a different order for every researcher.

1. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans (Nature Immunology)
2. Gout-associated uric acid crystals activate the NALP3 inflammasome (Nature)
3. Fungal β-Glucans and Mammalian Immunity
4. Dectin-1 Mediates the Biological Effects of β-Glucans (Journal of Experimental Medicine)
5. Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function (Journal of Experimental Medicine)
6. A Homozygous CARD9 Mutation in a Family with Susceptibility to Fungal Infections (New England Journal of Medicine)
7. Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2 (Journal of Experimental Medicine)
8. From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
9. Adaptive Immune Features of Natural Killer Cells (Nature)
10. Statistical significance for genomewide studies (Proceedings of the National Academy of Sciences of the United States of America)

Their papers

• Inflammasome is a central player in the induction of obesity and insulin resistance (2011) — 692 citations
• Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Immunity (2016) — 765 citations
• A guiding map for inflammation (2017) — 661 citations
• Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19 (2021) — 704 citations
• Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 (2021) — 1,528 citations
• Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 (2021) — 686 citations
• Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. (2020) — 768 citations
• A minimal common outcome measure set for COVID-19 clinical research (2020) — 1,467 citations
• Presence of Genetic Variants Among Young Men With Severe COVID-19. (2020) — 693 citations
• Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. (2018) — 799 citations
• Metabolic Induction of Trained Immunity through the Mevalonate Pathway. (2018) — 667 citations
• mTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity (2014) — 2,008 citations
• STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. (2011) — 631 citations
• Inflammasome activation and IL-1β and IL-18 processing during infection. (2011) — 699 citations
• Candida albicans morphogenesis and host defence: discriminating invasion from colonization (2011) — 853 citations